Anticancer Impact of Nitric Oxide (NO) and NO Combination with SMYD-3 Inhibitor on Breast Carcinomas

Despite enormous advances in the detection and treatment of breast cancer, it still remains the leading cancer diagnosis and has the second highest mortality rate. Thus, breast cancer research is a high priority for academics and clinicians alike. Based on previous research indicating the potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Jenna L., Hinsen, Kristin J., Reynolds, Melissa M., Brown, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628812/
https://www.ncbi.nlm.nih.gov/pubmed/34842655
http://dx.doi.org/10.3390/diseases9040082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628812/
https://www.ncbi.nlm.nih.gov/pubmed/34842655
http://dx.doi.org/10.3390/diseases9040082

Ejemplares similares